Senior insider sale
TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$2.55M
61.50K shares
What this filing means
BAYNES ROY D. plans to sell 61.50K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $2.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2026ACC: 0001950047-26-005979
61.50K
Shares to sell
$2.55M
Approx. market value
4.50K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/12/2026
4.50KTotal acquired4.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/12/2026 | Stock Option Exercise Cash | 4.50K | — |
| Total | 4.50K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
4.50K
Market value
$209.9K
5/5/2026
—Completed
Units to sell
9.75K
Market value
$431.1K
5/1/2026
—Completed
Units to sell
32.75K
Market value
$1.35M
4/14/2026
—Completed
Units to sell
10K
Market value
$330.0K
4/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.50K
Market value
$225.0K
6/12/2026
Total
Units
61.50K
Value
$2.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/5/2026 | 4.50K | $209.9K | — | Completed |
5/1/2026 | 9.75K | $431.1K | — | Completed |
4/14/2026 | 32.75K | $1.35M | — | Completed |
4/6/2026 | 10K | $330.0K | — | Completed |
| Planned — Approximate Date | ||||
6/12/2026 | 4.50K | $225.0K | NASDAQ | Planned |
| Total | 61.50K | $2.55M | ||